What is the correlation of risk between family members and intracranial (cerebral) aneurysms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Family members of individuals with brain aneurysms have a significantly higher risk of developing aneurysms themselves, with first-degree relatives having approximately 2-4 times greater risk than the general population, as supported by the guidelines from the American Heart Association/American Stroke Association 1.

Risk Factors and Screening

The risk of aneurysm development in family members is influenced by various factors, including:

  • Genetic conditions such as Autosomal Dominant Polycystic Kidney Disease, Ehlers-Danlos syndrome type IV, and Marfan syndrome
  • Family history of aneurysms or subarachnoid hemorrhages, particularly if two or more first-degree relatives are affected
  • Environmental factors like smoking and hypertension, which can further increase risk in genetically predisposed individuals

Screening Recommendations

Screening with non-invasive imaging such as magnetic resonance angiography (MRA) or CT angiography (CTA) is recommended for patients with two or more family members with intracranial aneurysms (IA) or subarachnoid hemorrhage (SAH), as well as those with a history of autosomal dominant polycystic kidney disease, especially if they have a family history of IA 1. Key points to consider:

  • The risk of aneurysm development in family members is significant, and screening can help identify asymptomatic aneurysms
  • Lifestyle modifications, such as quitting smoking and managing hypertension, are important for individuals with a family history of aneurysms
  • The guidelines from the American Heart Association/American Stroke Association provide recommendations for screening and management of patients with unruptured intracranial aneurysms, including those with a family history of aneurysms 1

From the Research

Correlation of Risk between Family Members and Brain Aneurysms

The correlation of risk between family members and brain aneurysms is a significant concern, with several studies investigating this relationship.

  • Individuals with two or more first-degree relatives who have had aneurysmal subarachnoid haemorrhage (aSAH) have an increased risk of aneurysms and aSAH 2.
  • The yield of long-term screening for intracranial aneurysms in individuals with a family history of aSAH is substantial, even after more than 10 years of follow-up and two initial negative screens 2.
  • Independent predictors of aneurysm detection on MR angiography include female sex, pack-years of cigarette smoking, and duration of hypertension 3.

Risk Factors and Predictors

Several risk factors and predictors have been identified, including:

  • Female sex, history of intracranial aneurysms/aneurysmal subarachnoid hemorrhage, and older age 4.
  • Smoking history, hypertension, and previous aneurysms 2, 3.
  • A family history of aneurysms, with individuals having two or more affected first-degree relatives at higher risk 2, 5.

Screening and Detection

Screening for intracranial aneurysms in individuals with a positive family history is recommended, with the following findings:

  • Individuals with ≥2 affected first-degree relatives have a greater prevalence of IA (average 13.1% vs. 3% in the general population) 5.
  • Serial screening over time can be cost-effective in persons with only one first-degree relative with IA or aSAH 5.
  • The risk of aSAH is also increased in individuals with a family history of aSAH or IA 2, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.